Liang Tao, Jiang Jiayi, Li Xinyi, Ma Haohan, Zhang Xiaonan, Deng Gang, Deng Weiping, Guan Lichang, Zhang Kaijun, Jiang Lei, Tan Ning, Cai Xujie, Xu Lishu
Department of General Surgery (Area 1), People's Hospital of Yingde City, Yingde, Guangdong, China.
Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
BMJ Open. 2025 Jan 20;15(1):e086432. doi: 10.1136/bmjopen-2024-086432.
The aim of this study is to derive and validate a reliable indicator for predicting an increased risk of postoperative mortality in elderly patients undergoing curative resection for colorectal cancer (CRC).
This study is of multicentre retrospective design.
A total of 1227 CRC patients undergoing curative resection (age ≥65 years) from three distinct cohorts were retrospective enrolled. Participant cohorts consisted of the derivation (n=845), external validation (n=95) and localised validation (n=287) groups. The carcinoembryonic antigen (CEA) to lymphocyte ratio (CLR) was derived from the derivation cohort and subsequently validated in two additional cohorts. The observed end point was all-cause death during the follow-up period postoperation.
In the derivation cohort, CLR demonstrated an independent association with all-cause mortality. In the two validation cohorts, CLR also presented a strong discriminatory ability in predicting postoperative all-cause death, with the area under the curve (AUC) of 0.68 in the external cohort and 0.78 in the localised cohort. Survival analyses revealed that CRC patients with CLR ≤2.53 tended to have better overall survival than those with CLR >2.53 (p<0.05 for all cohorts). Multivariate Cox proportional hazard models indicated that CLR ≤2.53 was significantly associated with reduced mortality risk in the derivation (HR: 0.405, p<0.001), external validation (HR: 0.519, p=0.039) and localised validation cohorts (HR: 0.167, p<0.001).
Preoperative CLR serves as a reliable predictor of all-cause death following curative resection in elderly patients with CRC. Individuals with CLR exceeding 2.53 are inclined to a lower overall survival probability.
本研究旨在推导并验证一个可靠指标,以预测接受结直肠癌(CRC)根治性切除术的老年患者术后死亡风险增加。
本研究为多中心回顾性设计。
从三个不同队列中回顾性纳入了1227例行根治性切除术的CRC患者(年龄≥65岁)。参与者队列包括推导组(n = 845)、外部验证组(n = 95)和局部验证组(n = 287)。癌胚抗原(CEA)与淋巴细胞比值(CLR)从推导队列中得出,随后在另外两个队列中进行验证。观察终点为术后随访期间的全因死亡。
在推导队列中,CLR显示出与全因死亡率独立相关。在两个验证队列中,CLR在预测术后全因死亡方面也具有很强的鉴别能力,外部队列的曲线下面积(AUC)为0.68,局部队列的AUC为0.78。生存分析显示,CLR≤2.53的CRC患者总体生存率往往高于CLR>2.53的患者(所有队列p<0.05)。多变量Cox比例风险模型表明,CLR≤2.53与推导组(HR:0.405,p<0.001)、外部验证组(HR:0.519,p = 0.039)和局部验证队列(HR:0.167,p<0.001)的死亡风险降低显著相关。
术前CLR可作为老年CRC患者根治性切除术后全因死亡的可靠预测指标。CLR超过2.53的个体总体生存概率较低。